Search

everythinglearnresearchcommunity

for

Search:↓

Using platelet-rich plasma injections and 5% minoxidil topically can safely and effectively treat mild-to-moderate male pattern baldness.

Stem cell therapies could be a promising alternative for hair loss treatment, but more research is needed to understand their full potential and safety.

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

The research identified genes and non-coding RNAs in cells that could be affected by testosterone, which may help understand hair loss and prostate cancer.

Fibrosing alopecia in a pattern distribution is a new type of scarring hair loss that resembles common baldness and an autoimmune skin disease.

Increasing COX-2 in mouse skin causes bigger sebaceous glands and thinner hair, but stopping COX-2 can reverse hair thinning.

Chemotherapy causes temporary hair loss in women, while Tamoxifen does not significantly affect hair, and genetics show no link between female pattern hair loss and common baldness genes.

Alopecia Areata is treated with drugs and therapies to reduce inflammation and immune response.

Higher alarin levels might link hair loss and metabolic syndrome.

Using both platelet-rich plasma and minoxidil together gives the best results for hair growth in male rats with hair loss.

The FAW-FS algorithm improves depression recognition, and psychological interventions help AGA patients' mental health.

Psoriasis, acne, and hair loss are linked to unhealthy cholesterol levels, increasing heart disease risk.

SFRP-4 might be an early indicator of diabetes and hypertension in men with androgenic alopecia.

Treat androgenetic alopecia early with recommended medications or consider hair grafts and wigs if unresponsive.

Four genetic risk areas related to male-pattern baldness were identified, with WNT signaling playing a role in its development.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth and could be a target for treating hair loss.

Finasteride reduces hair follicle cell death in androgenetic alopecia.

Lower vitamin D levels may contribute to female hair loss.

COVID-19-related hair loss may be linked to blood flow disorders and inflammation.

Early hair loss in men could be a sign of non-cancerous prostate enlargement, and treating hair loss early might help prevent prostate issues later.

Hair loss can be an early sign of prostate enlargement.

17α-estradiol boosts aromatase activity in female hair follicles, potentially helping with hair loss.

Microneedling can effectively promote new hair growth in men with hair loss who didn't improve with traditional treatments.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Minoxidil can reduce functions related to androgen receptors.

Inflammation may play a role in causing androgenetic alopecia.

Targeting a protein that blocks hair growth with microRNAs could lead to new hair loss treatments, but more research is needed.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

Psoriasis patients have different skin bacteria, which may cause flare-ups.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.